These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8150114)

  • 1. Comparison between nafarelin and leuprolide acetate for in vitro fertilization: preliminary clinical study.
    Dantas ZN; Vicino M; Balmaceda JP; Asch RH; Stone SC
    Fertil Steril; 1994 Apr; 61(4):705-8. PubMed ID: 8150114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
    Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
    Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial.
    Avrech OM; Goldman GA; Pinkas H; Amit S; Neri A; Zukerman Z; Ovadia J; Fisch B
    Gynecol Endocrinol; 1996 Jun; 10(3):165-70. PubMed ID: 8862491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.
    Surrey ES; Bower J; Hill DM; Ramsey J; Surrey MW
    Fertil Steril; 1998 Mar; 69(3):419-24. PubMed ID: 9531870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nafarelin acetate for pituitary down-regulation in in vitro fertilization. Comparison of two dosages.
    Yuzpe AA; Nisker JA; Kaplan BR; Tummon IS; Auckland J
    J Reprod Med; 1995 Feb; 40(2):83-8. PubMed ID: 7738933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nafarelin versus leuprolide in ovulation induction for in vitro fertilization: a randomized clinical trial.
    Penzias AS; Shamma FN; Gutmann JN; Jones EE; DeCherney AH; Lavy G
    Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):739-42. PubMed ID: 1533022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of nafarelin acetate versus leuprolide acetate in conjunction with human menopausal gonadotropins for superovulation/intrauterine insemination.
    Schmidt-Sarosi CL; Yerovi LA
    Int J Fertil Menopausal Stud; 1994; 39(1):20-5. PubMed ID: 8167676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles.
    Lockwood GM; Pinkerton SM; Barlow DH
    Hum Reprod; 1995 Feb; 10(2):293-8. PubMed ID: 7769051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles.
    Givens CR; Schriock ED; Dandekar PV; Martin MC
    Fertil Steril; 1994 Nov; 62(5):1011-7. PubMed ID: 7926111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of a combination administration of gonadotropin-releasing hormone agonist and gonadotropins for controlled ovarian hyperstimulation in IVF program.
    Chang YS; Kim SH; Shin CJ; Kim JG; Moon SY; Lee JY
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):337-45. PubMed ID: 2129188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
    Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
    Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous LH surge versus hCG as ovulation trigger after low-dose highly purified FSH in IUI: a comparison of 761 cycles.
    Romeu A; Monzó A; Peiró T; Diez E; Peinado JA; Quintero LA
    J Assist Reprod Genet; 1997 Oct; 14(9):518-24. PubMed ID: 9401870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.
    Schoolcraft W; Schlenker T; Gee M; Stevens J; Wagley L
    Fertil Steril; 1997 Jan; 67(1):93-7. PubMed ID: 8986690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
    Younis JS; Matilsky M; Radin O; Ben-Ami M
    Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women.
    Gelety TJ; Pearlstone AC; Surrey ES
    Fertil Steril; 1995 Dec; 64(6):1074-80. PubMed ID: 7589655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value assessment of the early response of blood estradiol, FSH, and LH using leuprolide acetate during ovarian hyperstimulation in assisted reproduction].
    Sondón García Z; Alvarado A; Peraza Briones C; González Sánchez R; Jiménez Perea L
    Ginecol Obstet Mex; 2001 Feb; 69():65-71. PubMed ID: 11339176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of using ganirelix acetate versus a 4-day follicular phase leuprolide acetate protocol in unselected women undergoing in vitro fertilization.
    Posada MN; Vlahos NP; Jurema MW; Bracero NJ; Wallach EE; Garcia JE
    Fertil Steril; 2003 Jul; 80(1):103-10. PubMed ID: 12849810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.